Brain Tumors

Listen: Mayo Clinic Radio 11/9/19

Artificial intelligence is being used at Mayo Clinic to detect heart disease, treat stroke patients faster and create algorithms for diagnostic radiology. On the Mayo [...]

Artificial intelligence is being used at Mayo Clinic to detect heart disease, treat stroke patients faster and create algorithms for diagnostic radiology. On the Mayo Clinic Radio podcast, Dr. Bradley [...]

When you think of artificial intelligence (AI), you might imagine what you see in the movies: robots, self-driving vehicles, and computers that think and act [...]

When you think of artificial intelligence (AI), you might imagine what you see in the movies: robots, self-driving vehicles, and computers that think and act [...]

Entering the Mathematical Neuro-Oncology lab on Mayo Clinic’s location in Scottsdale, Arizona, is like walking onto the bridge of a ship in some fictional universe. There's a [...]

An estimated 20 million Americans have sleep apnea, and many don’t even know it. Sleep apnea is a potentially serious sleep disorder in which breathing repeatedly stops [...]

Learn more about brain tumors. Other health tip infographics:mayoclinichealthhighlights.startribune.com

Brain tumors: Diagnosis and treatment Brain tumors can begin in your brain (primary brain tumors), or cancer can begin in other parts of your body and [...]

Nearly 80,000 new cases of primary brain tumors are expected to be diagnosed this year in the U.S. A brain tumor is a mass or [...]

Tastes change during cancer treatment: Try more vegetables During and after treatment for cancer, your tastes can change and you may prefer vegetables over [...]

On this special New Year's edition of Mayo Clinic Radio, we look back at some of the leading-edge research featured on the program in 2015. Dr. Robert [...]

ROCHESTER, Minn. — The molecular makeup of brain tumors can be used to sort patients with gliomas into five categories, each with different clinical features and outcomes, researchers at Mayo Clinic and the University of California San Francisco have shown. The finding could change the methods that physicians rely on to determine prognosis and treatment options. Previously, they relied on how patients’ tumors look under the microscope. The study is published online in the  New England Journal of Medicine. “Our findings are going to weigh heavily on the future classification of brain tumors. The time of classifying these tumors solely according to histology as astrocytoma, oligodendroglioma or mixed oligoastrocytoma could be a thing of the past,” says lead study author Daniel H. Lachance, M.D., a neuro oncologist at Mayo Clinic. “This molecular data helps us better classify glioma patients, so we can begin to understand who needs to be treated more aggressively and who might be able to avoid unnecessary therapies.” http://youtu.be/76YHqUxXZVs